Resultados da busca - Funt, Samuel
- Mostrando 1 - 20 resultados de 42
- Ir para a próxima página
-
1
-
2
-
3
‘Case of the Month’ from Memorial Sloan Kettering Cancer Center, New York, NY, USA: managing newly diagnosed metastatic testicular germ cell tumour in a COVID‐19‐positive patient... por Almassi, Nima, Mulhall, John P., Funt, Samuel A., Sheinfeld, Joel
Publicado em 2020Texto -
4
-
5
-
6
-
7
Increased anxiety and other similarities in temperament of alcoholics with and without antisocial personality disorder across three diverse populations por Ducci, Francesca, Enoch, Mary-Anne, Funt, Samuel, Virkkunen, Matti, Albaugh, Bernard, Goldman, David
Publicado em 2007Texto -
8
The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer por van Dijk, Nick, Funt, Samuel A., Blank, Christian U., Powles, Thomas, Rosenberg, Jonathan E., van der Heijden, Michiel S.
Publicado em 2018Texto -
9
Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in—Time to Start Backing Out por van de Wetering, Rune A.W., Sleijfer, Stefan, Feldman, Darren R., Funt, Samuel A., Bosl, George J., de Wit, Ronald
Publicado em 2018Texto -
10
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes por Solovyov, Alexander, Vabret, Nicolas, Arora, Kshitij S., Snyder, Alexandra, Funt, Samuel A., Bajorin, Dean F., Rosenberg, Jonathan E., Bhardwaj, Nina, Ting, David T., Greenbaum, Benjamin D.
Publicado em 2018Texto -
11
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors por Funt, Samuel A., Patil, Sujata, Feldman, Darren R., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel, Tickoo, Satish K., Reuter, Victor E., Bosl, George J.
Publicado em 2019Texto -
12
ROLE OF INTERLEUKIN 17 IN INFLAMMATION, ATHEROSCLEROSIS AND VASCULAR FUNCTION IN APOLIPOPROTEIN E-DEFICIENT MICE por Madhur, Meena S., Funt, Samuel A., Li, Li, Vinh, Antony, Chen, Wei, Lob, Heinrich E., Iwakura, Yoichiro, Blinder, Yelena, Rahman, Ayaz, Quyyumi, Arshed A., Harrison, David G.
Publicado em 2011Texto -
13
A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor por Leiserson, Mark D. M., Syrgkanis, Vasilis, Gilson, Amy, Dudik, Miroslav, Gillett, Sharon, Chayes, Jennifer, Borgs, Christian, Bajorin, Dean F., Rosenberg, Jonathan E., Funt, Samuel, Snyder, Alexandra, Mackey, Lester
Publicado em 2018Texto -
14
Pretreatment Eosinophil Counts in Patients with Advanced or Metastatic Urothelial Carcinoma Treated with Anti–PD-1/PD-L1 Checkpoint Inhibitors por Mota, Jose Mauricio, Teo, Min Yuen, Whiting, Karissa, Li, Han A., Regazzi, Ashley Marie, Lee, Chung-Han, Funt, Samuel A., Bajorin, Dean, Ostrovnaya, Irina, Iyer, Gopa, Rosenberg, Jonathan E.
Publicado em 2021Texto -
15
Tumor immunology and cancer immunotherapy: summary of the 2014 SITC primer por Page, David B., Bourla, Ariel Bulua, Daniyan, Anthony, Naidoo, Jarushka, Smith, Eric, Smith, Melody, Friedman, Claire, Khalil, Danny N., Funt, Samuel, Shoushtari, Alexander N., Overwijk, Willem W., Sharma, Padmanee, Callahan, Margaret K.
Publicado em 2015Texto -
16
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma por Pianko, Matthew J., Funt, Samuel A., Page, David B., Cattry, Deepika, Scott, Emma C., Ansell, Stephen M., Borrello, Ivan M., Gutierrez, Martin, Lendvai, Nikoletta, Hassoun, Hani, Landgren, C. Ola, Lesokhin, Alexander M.
Publicado em 2017Texto -
17
Thoracic Metastasectomy in Germ Cell Tumor Patients Treated with First-Line Versus Salvage Therapy por Caso, Raul, Jones, Gregory D., Tan, Kay See, Bosl, George J., Funt, Samuel A., Sheinfeld, Joel, Reuter, Victor E., Amar, David, Fischer, Gregory, Molena, Daniela, Rocco, Gaetano, Bains, Manjit S., Feldman, Darren R., Jones, David R.
Publicado em 2020Texto -
18
Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors por McHugh, Deaglan J., Funt, Samuel A., Silber, Deborah, Knezevic, Andrea, Patil, Sujata, O’Donnell, Devon, Tsai, Stephanie, Reuter, Victor E., Sheinfeld, Joel, Carver, Brett S., Motzer, Robert J., Bajorin, Dean F., Bosl, George J., Feldman, Darren R.
Publicado em 2020Texto -
19
Dermatologic Adverse Events Related to the PI3Kα Inhibitor Alpelisib (BYL719) in Patients with Breast Cancer por Wang, Diana G., Barrios, Dulce M., Blinder, Victoria S., Bromberg, Jacqueline F., Drullinsky, Pamela R., Funt, Samuel A., Jhaveri, Komal L., Lake, Diana E., Lyons, Tomas, Modi, Shanu, Razavi, Pedram, Sidel, Michelle, Traina, Tiffany A., Vahdat, Linda T., Lacouture, Mario E.
Publicado em 2020Texto -
20
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors. por Caso, Raul, Jones, Gregory D., Bains, Manjit S., Hsu, Meier, Tan, Kay See, Feldman, Darren R., Funt, Samuel A., Reuter, Victor E., Bosl, George J., McHugh, Deaglan, Huang, James, Molena, Daniela, Amar, David, Fischer, Gregory, Rusch, Valerie W., Jones, David R.
Publicado em 2021Texto